September 6, 2007
AstraZeneca cuts through volatility with $7bn bond sale Duncan Kerr - Financial News Online US
AstraZeneca cuts through volatility with $7bn bond sale Duncan KerrFinancial News Online US, UK - 2 hours agoPharmaceutical company AstraZeneca yesterday returned to the primary debt market for the first time in over three years to successfully sell close to $7bn …For AstraZeneca at least, the cost of money is going up FT Alphavilleall 2 news articles
Read full story